232 related articles for article (PubMed ID: 34407350)
1. Audio Interview: Aspects of Covid-19 Immunity.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2021 Aug; 385(8):e31. PubMed ID: 34407350
[No Abstract] [Full Text] [Related]
2. Audio Interview: Monoclonal Antibodies and Vaccine Boosts.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2021 Jul; 385(3):e18. PubMed ID: 34260844
[No Abstract] [Full Text] [Related]
3. Audio Interview: Planning for the SARS-CoV-2 Vaccine Rollout.
Rubin EJ; Baden LR; Lee TH; Morrissey S
N Engl J Med; 2021 Jan; 384(1):e13. PubMed ID: 33406335
[No Abstract] [Full Text] [Related]
4. Audio Interview: New Evidence on SARS-CoV-2 Vaccine Boosters.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2021 Sep; 385(12):e48. PubMed ID: 34525292
[No Abstract] [Full Text] [Related]
5. Audio Interview: Efficacy of Current Covid-19 Vaccines against Variant Viruses.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2021 Mar; 384(11):e53. PubMed ID: 33730461
[No Abstract] [Full Text] [Related]
6. Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain.
Yang M; Li J; Huang Z; Li H; Wang Y; Wang X; Kang S; Huang X; Wu C; Liu T; Jia Z; Liang J; Yuan X; He S; Chen X; Zhou Z; Chen Q; Liu S; Li J; Zheng H; Liu X; Li K; Yao X; Lang B; Liu L; Liao HX; Chen S
Microbiol Spectr; 2021 Oct; 9(2):e0135221. PubMed ID: 34643438
[TBL] [Abstract][Full Text] [Related]
7. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.
Wang P; Nair MS; Liu L; Iketani S; Luo Y; Guo Y; Wang M; Yu J; Zhang B; Kwong PD; Graham BS; Mascola JR; Chang JY; Yin MT; Sobieszczyk M; Kyratsous CA; Shapiro L; Sheng Z; Huang Y; Ho DD
Nature; 2021 May; 593(7857):130-135. PubMed ID: 33684923
[TBL] [Abstract][Full Text] [Related]
8. Audio Interview: A Look at Covid-19 Prevention and Care in 2020.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2020 Dec; 383(27):e147. PubMed ID: 33382936
[No Abstract] [Full Text] [Related]
9. On the road to ending the COVID-19 pandemic: Are we there yet?
Case JB; Winkler ES; Errico JM; Diamond MS
Virology; 2021 May; 557():70-85. PubMed ID: 33676349
[TBL] [Abstract][Full Text] [Related]
10. Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development?
Lu L; Zhang H; Zhan M; Jiang J; Yin H; Dauphars DJ; Li SY; Li Y; He YW
Sci China Life Sci; 2020 Dec; 63(12):1833-1849. PubMed ID: 33355886
[TBL] [Abstract][Full Text] [Related]
11. What do we know about the antibody responses to SARS-CoV-2?
Lagunas-Rangel FA; Chávez-Valencia V
Immunobiology; 2021 Mar; 226(2):152054. PubMed ID: 33524881
[TBL] [Abstract][Full Text] [Related]
12. Fast-spreading COVID variant can elude immune responses.
Callaway E
Nature; 2021 Jan; 589(7843):500-501. PubMed ID: 33479534
[No Abstract] [Full Text] [Related]
13. Structural Analysis of Neutralizing Epitopes of the SARS-CoV-2 Spike to Guide Therapy and Vaccine Design Strategies.
Finkelstein MT; Mermelstein AG; Parker Miller E; Seth PC; Stancofski ED; Fera D
Viruses; 2021 Jan; 13(1):. PubMed ID: 33477902
[TBL] [Abstract][Full Text] [Related]
14. Passive Immunity for Coronavirus Disease 2019: A Commentary on Therapeutic Aspects Including Convalescent Plasma.
Lindholm PF; Ramsey G; Kwaan HC
Semin Thromb Hemost; 2020 Oct; 46(7):796-803. PubMed ID: 32526774
[TBL] [Abstract][Full Text] [Related]
15. Audio Interview: Waning Immunity against SARS-CoV-2.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2021 Dec; 385(24):e99. PubMed ID: 34879456
[No Abstract] [Full Text] [Related]
16. Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum.
Uriu K; Kimura I; Shirakawa K; Takaori-Kondo A; Nakada TA; Kaneda A; Nakagawa S; Sato K;
N Engl J Med; 2021 Dec; 385(25):2397-2399. PubMed ID: 34731554
[No Abstract] [Full Text] [Related]
17. B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination.
Arora P; Sidarovich A; Krüger N; Kempf A; Nehlmeier I; Graichen L; Moldenhauer AS; Winkler MS; Schulz S; Jäck HM; Stankov MV; Behrens GMN; Pöhlmann S; Hoffmann M
Cell Rep; 2021 Oct; 37(2):109825. PubMed ID: 34614392
[TBL] [Abstract][Full Text] [Related]
18. Intranasal COVID-19 vaccines: From bench to bed.
Alu A; Chen L; Lei H; Wei Y; Tian X; Wei X
EBioMedicine; 2022 Feb; 76():103841. PubMed ID: 35085851
[TBL] [Abstract][Full Text] [Related]
19. Pan-Sarbecovirus Neutralizing Antibodies in BNT162b2-Immunized SARS-CoV-1 Survivors.
Tan CW; Chia WN; Young BE; Zhu F; Lim BL; Sia WR; Thein TL; Chen MI; Leo YS; Lye DC; Wang LF
N Engl J Med; 2021 Oct; 385(15):1401-1406. PubMed ID: 34407341
[TBL] [Abstract][Full Text] [Related]
20. Neutralization of SARS-CoV-2 Variants by Serum from BNT162b2 Vaccine Recipients.
Valleriani F; Mancuso E; Vincifori G; Teodori L; Di Marcantonio L; Spedicato M; Leone A; Savini G; Morelli D; Bonfini B; Lorusso A
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
